Fifth Third Bancorp’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,532
Closed -$149K 3002
2015
Q1
$149K Buy
1,532
+581
+61% +$56.5K ﹤0.01% 1069
2014
Q4
$88K Buy
+951
New +$88K ﹤0.01% 1206